Incretin-based cardiovascular protection beyond diabetes: evidence, mechanisms, and therapeutic frontiers from GLP-1 receptor agonists to multi-agonist therapy

• by Libin Qiu, Jinpeng Liu, Nana Hu

• July 2, 2026

Family cohesion and adaptability in heart failure: an APIMeM analysis of symptom perception and spousal caregiving on patient self-care

• by Yan Yang, Jianhua Shi, Xiaoying Gu

• June 19, 2026

Elastography Distinguishes Cardiac Amyloidosis Types

Shear wave velocity measurements in the basal anteroseptal and right ventricular walls differed between transthyretin and light chain cardiac amyloidosis when conventional echocardiographic parameters did not.

• by Kathryn Wighton

• June 28, 2026

• 3 min

Heart Failure Medication Withdrawal in Patients With Improved Cardiac Function After Atrial Fibrillation

• by Sitong Li, Yidan Sun, Yiwei Lai, Hui Wang, Jiancheng Han, Yuge Zhang, Mingyang Gao, Jue Wang, Jingrui Zhang, Liu He, Jing Cui, Xueyuan Guo, Song Zuo, Xiaoxia Liu, Nian Liu, Songnan Li, Ning Zhou, Ribo Tang, Deyong Long, Caihua Sang, Xin Du, Jianzeng Dong, Changsheng Ma

• June 26, 2026